The global Cell Expansion Market depicts a highly consolidated structure to exist in its vendor landscape, owing to the presence of a handful of players, says Transparency Market Research based on a recently published report. Leading players in the market are increasing the rate of investments, thereby cementing their position in the global cell expansion market. The companies are also carrying out extensive research-based activities to develop advanced cell expansion applications. In the next few years, most companies are expected to shift their focus to achieve product differentiation. Presence of a variety of services along with new players regularly making their foray in the market is expected to intensify the competition during the next few years.
The global cell expansion market is expected to grow at a stellar CAGR of 14.70% during the forecast period from 2016 to 2024. The market initially had gained a revenue worth US$7.7 bn in 2015, which is further expected to increase up to US$26 bn by 2024.
Takara Bio, Inc., Corning Incorporated, GE Healthcare, Terumo Corporation, Octane Biotech, Inc., Lonza Group, Danaher Corporation (Pall Corporation), Eppendorf AG, PeproTech, Inc., Becton, Dickinson and Company, STEMCELL Technologies, Merck Millipore (Merck KGaA), Bio-Techne (R&D Systems), Cell Signaling Technology, Inc., Thermo Fisher Scientific, Inc., and HiMedia Laboratories, and CellGenix GmbH, are key players operating in the global cell expansion market.
Request to View Sample of Report –
The global cell expansion market is gaining extensive growth mainly due to widespread prevalence of chronic medical conditions, which further increasing the need for use of cell expansion-based processes. The preference for regenerative medicines is also fast rising, which is greatly expected to propel the global cell expansion market’s growth in the near future.
As newer cell-based therapies are introduced, the number of patients who want to utilize the treatments increases, consequently making the market gain extensive growth. Lastly, a rise in biopharmaceuticals is another factor, which is likely to augur the global cell expansion market to expand substantially during the upcoming years.